Climopax is a pharmaceutical raw material used as the active ingredient in conjugated estrogen products. According to California Labor Code and federal labeling requirements, conjugated estrogens can cause cancer and developmental toxicity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Climopax?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Alendronate sodium trihydrate
pharmaceutical raw material
Wz-4002
pharmaceutical raw material
Azithromycin monohydrate
pharmaceutical raw material
{[({[2-(2,6-Dichloroanilino)phenyl]acetyl}oxy)acetyl]oxy}acetic acid
pharmaceutical raw material
3-Oleoylestrone-2,4,16,16-D4
research compound
sodium [(13S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] sulfate
VUCAHVBMSFIGAI-TWCWWGPMSA-M
C[C@]12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[Na+]
Sourcing Climopax?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.